Volume 30, Issue 141 (July & August 2022)                   J Adv Med Biomed Res 2022, 30(141): 319-326 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shabani M, Eshaghian M, Mazloomzadeh S. The Effect of Sertreline Versus Nortriptyline on Quality of Life and Depression After Stroke:A Randomized Double-Blind Controlled Study. J Adv Med Biomed Res 2022; 30 (141) :319-326
URL: http://journal.zums.ac.ir/article-1-6528-en.html
1- Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
2- Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran , smazloomzadeh@zums.ac.ir
Abstract:   (60484 Views)

Background and Objective: Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants are utilized for treatment of post stroke depression, reduced quality of life and poor compliance.  This study compared the effects of sertraline and nortriptyline on the quality of life and depression in post-stroke patients.
Materials and Methods: This randomized double-blind trial was conducted on 56 stroke patients admitted to Valiasr Hospital in Zanjan, Iran, 2016. Patients were randomly allocated in two groups by simple randomization and received sertraline in one group, nortriptyline in the other and nobody received placebo. Patients were screened for depression using BDI (II) questionnaire and those without depression were entered into study. During follow-up, patients completed a quality of life questionnaire named Nottingham Health Profile (NHP). Data were analysed using repeated measure and Bonferroni tests in SPSS 22. P<0.05 was considered statistically significant.
Results: The mean age of patients in sertraline and nortriptyline groups were 61.7 and 63.6, respectively (P=0.194). No significant differences were observed for sex, marital status and education between two groups. The mean score of total quality of life and its dimensions decreased significantly during 6 months for both groups (P=0.001). The effect of sertraline in these reductions was not different from nortriptyline (P=0.60). The proportions of moderate or severe depression were 17.9% and 37.0% in sertraline and nortriptyline groups, respectively (P=0.24).
Conclusion: Both sertraline and nortriptyline improved all aspects of quality of life and their effect on prevention of depression was similar. Therefore, the administration of sertraline or nortriptyline could be beneficial in post-stroke patients.

Full-Text [PDF 483 kb]   (30804 Downloads) |   |   Full-Text (HTML)  (944 Views)  

 Both sertraline and nortriptyline improved all aspects of quality of life and their effect on prevention of depression was similar. Therefore, the administration of sertraline or nortriptyline could be beneficial in post-stroke patients.


Type of Study: Clinical Trials | Subject: Clinical medicine
Received: 2021/04/28 | Accepted: 2022/06/15 | Published: 2022/06/30

References
1. Simon R, Greenberg D, Aminoff M. Clinical neurology 5th edition. 2009.
2. Sadock B, Sadock V. eds. Compre-hensive Textbook of Psychiatry, 9th edn: Phila-delphia. Lippincott Williams Wilkins; 2009.
3. Kaadan MI, Larson MJ. Management of post-stroke depression in the Middle East and North Africa: Too little is known. J Neurol Sci. 2017;378:220-4. [DOI:10.1016/j.jns.2017.05.026] [PMID]
4. Timmerby N, Andersen JH, Søndergaard S, Østergaard SD, Bech P. A systematic review of the clinimetric properties of the 6-item version of the Hamilton Depression Rating Scale (HAM-D6). Psychother Psychosomatic. 2017;86(3):141-9. [DOI:10.1159/000457131] [PMID]
5. Opara JA, Jaracz K. Quality of life of post-stroke patients and their caregivers. J Med Life. 2010;3(3):216.
6. Lökk J, Delbari A. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat. 2010;6:539. [DOI:10.2147/NDT.S7637] [PMID] [PMCID]
7. Srivastava A, Taly AB, Gupta A, Murali T. Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol. 2010;13(2):123. [DOI:10.4103/0972-2327.64643] [PMID] [PMCID]
8. Khedr EM, Abdelrahman AA, Desoky T, Zaki AF, Gamea A. Post-stroke depression: frequency, risk factors, and impact on quality of life among 103 stroke patients-hospital-based study. Egypt J Neurol, Psychiatr Neurosurg. 2020;56(1):1-8. [DOI:10.1186/s41983-019-0128-1]
9. Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatr. 2016;173(3):221-31. [DOI:10.1176/appi.ajp.2015.15030363] [PMID]
10. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatr. 2000;157(3):351-9. [DOI:10.1176/appi.ajp.157.3.351] [PMID]
11. Mikami K, Jorge RE, Adams Jr HP, et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatric Psychiatr. 2011;19(12):1007-15. [DOI:10.1097/JGP.0b013e31821181b0] [PMID] [PMCID]
12. Feng R, Wang P, Gao C, et al. Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis. Medicine. 2018;97(49). [DOI:10.1097/MD.0000000000013453] [PMID] [PMCID]
13. Bai Zf, Wang Ly. Efficacy of sertraline for post-stroke depression: A systematic review protocol of randomized controlled trial. Medicine. 2019;98(16). [DOI:10.1097/MD.0000000000015299] [PMID] [PMCID]
14. Gorashizadeh MA, Shaafee S, Herizchi Ghadim S, et al. A study of sertralin efficacy on reducing disabilites in stroke in patients: A dobule blind randomized clinical trial. J Urmia Univ Med Sci. 2014;25(2):97-104.
15. Ayis SA, Ayerbe L, Crichton SL, Rudd AG, Wolfe CD. The natural history of depression and trajectories of symptoms long term after stroke: The prospective south London stroke register. J Affect Disorder. 2016;194:65-71. [DOI:10.1016/j.jad.2016.01.030] [PMID]
16. Hornsten C, Lövheim H, Gustafson Y. The association between stroke, depression, and 5-year mortality among very old people. Stroke. 2013;44(9):2587-9. [DOI:10.1161/STROKEAHA.113.002202] [PMID]
17. Bilge C, Kocer E, Kocer A, Turk Boru U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Europ J Phys Rehabil Med. 2008;44(1):13.
18. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke. 2013;44(3):844-50. [DOI:10.1161/STROKEAHA.112.673947] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb